Cargando…

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736985/
https://www.ncbi.nlm.nih.gov/pubmed/19765269
http://dx.doi.org/10.1186/1897-4287-5-3-119
_version_ 1782171390221221888
collection PubMed
description
format Text
id pubmed-2736985
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27369852009-09-03 Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers Hered Cancer Clin Pract Commentary BioMed Central 2007-09-15 /pmc/articles/PMC2736985/ /pubmed/19765269 http://dx.doi.org/10.1186/1897-4287-5-3-119 Text en
spellingShingle Commentary
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title_full Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title_fullStr Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title_full_unstemmed Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title_short Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
title_sort discussion on the use of taxanes for treatment of breast cancers in brca1 mutations carriers
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736985/
https://www.ncbi.nlm.nih.gov/pubmed/19765269
http://dx.doi.org/10.1186/1897-4287-5-3-119